Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

• Status: Completed
• Trial end date: 2012-07-01

Summary

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI).

• Phase: Phase 3

Details

• Lead Sponsor: AstraZeneca
• Treatments: Aspirin; Clopidogrel; Ticagrelor; Ticlopidine